IP Library Granted Patent US 12,623,062
Granted Patent B2
US 12,623,062 · App. 17/901,165 · Granted May 12, 2026

Radial access balloon catheter

Inventors: Michael Reynolds (Galway, IE); Simon Davis (Galway, IE)
Assignee: Surmodics MD, LLC
A61M25/1025A61M25/0054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,623,062
App. No.
17/901,165
Granted
May 12, 2026
Kind
B2
Abstract

Discussed herein are various embodiments related to a catheter assembly. The catheter assembly can include a catheter body extending between a proximal portion and a distal portion. The catheter body can include a sleeve and a hypotube, connected by at least one bond site, and separated by a floating gap. The hypotube can include at least one flow opening extending from the hypotube lumen to a stagnation zone, configured to permit flow between the stagnation zone and the hypotube lumen.

Claims (42)

1 . A catheter assembly comprising:

a catheter body extending between a proximal portion and a distal portion, the catheter body including:

a sleeve extending between the proximal and distal portions, wherein the sleeve includes a sleeve lumen;

a hypotube having a hypotube lumen, the hypotube extends between the proximal and distal portions and is received within the sleeve lumen;

at least one bond site connecting the sleeve to the hypotube, wherein the hypotube and the sleeve are spaced forming a floating gap distal to the at least one bond site, and

wherein the hypotube includes at least one flow opening extending from the hypotube lumen to the floating gap, and the at least one flow opening is configured to permit flow between the floating gap and the hypotube lumen;

wherein the sleeve includes at least one floating segment and one or more bond sites along the catheter body, wherein the at least one floating segment of the sleeve is moveable relative to the hypotube, and the one or more bond sites of the floating sleeve are interconnected with the hypotube.

2 . The catheter assembly of claim 1 , further comprising a stagnation zone along at least a portion of the floating gap.

3 . The catheter assembly of claim 1 , wherein the floating gap is proximate the at least one bond site.

4 . The catheter assembly of claim 1 , wherein the at least one flow opening is positioned adjacent to the at least one bond site.

5 . The catheter assembly of claim 1 , wherein the at least one flow opening comprises a plurality of flow openings arranged in a spiral around the hypotube.

6 . The catheter assembly of claim 1 , wherein the at least one flow opening is configured for movement of fluid therethrough.

7 . The catheter assembly of claim 1 , further comprising a balloon fluidly connected to the distal portion of the catheter body.

8 . The catheter assembly of claim 7 , wherein the balloon is actuatable between an expanded state and a collapsed state.

9 . The catheter assembly of claim 8 , wherein when the balloon is actuated between the expanded state and the collapsed state, the least one flow opening is configured to expel fluid.

10 . The catheter assembly of claim 7 , wherein the at least one flow opening is configured to allowing fluid flow therethrough during inflation of the balloon.

11 . The catheter assembly of claim 7 , wherein the at least one flow opening is configured to allowing fluid flow therethrough during deflation of the balloon.

12 . The catheter assembly of claim 7 , wherein the at least one flow opening is configured to allowing fluid flow therethrough during priming of the assembly.

13 . The catheter assembly of claim 1 , wherein the at least one flow opening is configured to reduce buildup of bubbles in a stagnation zone.

14 . The catheter assembly of claim 1 , wherein the at least one flow opening is configured to encourage fluid flow in a stagnation zone.

15 . The catheter assembly of claim 1 , wherein the at least one flow opening each comprise a diameter of less than about 0.20 mm.

16 . The catheter assembly of claim 1 , wherein the at least one flow opening each comprise a circular cross-section.

17 . The catheter assembly of claim 1 , wherein the at least one flow opening each comprise a non-circular cross-section.

18 . The catheter assembly of claim 1 , wherein the at least one flow opening is situated about one third of the way along the hypotube from the proximal portion.

19 . The catheter assembly of claim 1 , wherein the hypotube comprises a spiral cut.

20 . The catheter assembly of claim 19 , wherein the spiral cut comprises a continuous cut around an external surface of the hypotube.

21 . The catheter assembly of claim 19 , wherein the spiral cut comprises a first pitch angle and second pitch angle.

22 . The catheter assembly of claim 21 , wherein the second pitch angle is lesser than the first pitch angle.

23 . The catheter assembly of claim 21 , wherein the second pitch angle is larger than the first pitch angle.

24 . The catheter assembly of claim 21 , wherein the spiral cut gradually changes from the first pitch angle to the second pitch angle along the hypotube from the distal portion of the assembly to the proximal portion of the assembly.

25 . The catheter assembly of claim 21 , wherein the at least one flow opening is situated on the hypotube between the spiral cut and the proximal portion.

26 . A catheter assembly comprising:

a catheter body extending between a proximal portion and a distal portion, the catheter body including:

a hypotube extending between the proximal and distal portions,

a plurality of flow openings on the hypotube, wherein the plurality of flow openings are situated on the hypotube in a stagnation zone; and

a sleeve coupled around the hypotube and extending between the proximal and distal portions, the sleeve coupled to the hypotube by at least one bond site, wherein the sleeve is spaced from the hypotube by a floating gap;

wherein the plurality of flow openings are configured to allow flow between the hypotube and the floating gap in the stagnation zone;

wherein the sleeve includes at least one floating segment and one or more bond sites along the catheter body, wherein the at least one floating segment of the sleeve is moveable relative to the hypotube, and the one or more bond sites of the floating sleeve are interconnected with the hypotube; and

a balloon fluidly connected to the distal portion of the catheter body, the balloon configured to be inflated and deflated by movement of fluid through the catheter body, wherein the plurality of flow openings allow for fluid through the stagnation zone during inflation and deflation of the balloon.

27 . The catheter assembly of claim 26 , wherein during inflation fluid flows from the hypotube into the balloon and expands the balloon, and wherein during inflation the plurality of flow openings relieve stagnation in the floating gap.

28 . The catheter assembly of claim 26 , wherein during deflation fluid flows from the balloon out the hypotube, and wherein during deflation the plurality of flow openings relieve stagnation in the floating gap.

29 . The catheter assembly of claim 28 , wherein stagnation comprises blockage, bubbles, fluid buildup, or combinations thereof, in the floating gap.

Assignments (2)
SECURITY INTEREST Recorded Jan 21, 2026
From: SURMODICS MD, LLC
To: BANK OF MONTREAL, AS COLLATERAL AGENT
Reel/Frame 074461/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2023
From: REYNOLDS, MICHAEL; DAVIS, SIMON
To: SURMODICS MD, LLC
Reel/Frame 063521/0425 →
Continuity (2)
Provisional Application 63239717 · Sep 1, 2021
Related Publication 20230071144A1 · Mar 9, 2023
References Cited (147)
US 4170996A · Wu · 1979 [cited by applicant]
US 4921482A · Hammerslag et al. · 1990 [cited by applicant]
US 5060660A · Gambale et al. · 1991 [cited by applicant]
US 5203772A · Hammerslag et al. · 1993 [cited by applicant]
US 5449343A · Samson et al. · 1995 [cited by applicant]
US 5549552A · Peters et al. · 1996 [cited by applicant]
US 6071273A · Euteneuer · 2000 [cited by examiner]
US 6152912A · Jansen et al. · 2000 [cited by applicant]
US 6228073B1 · Noone et al. · 2001 [cited by applicant]
US 6595989B1 · Schaer · 2003 [cited by applicant]
US 6626889B1 · Simpson et al. · 2003 [cited by applicant]
US 6676643B2 · Brushey · 2004 [cited by applicant]
US 6702782B2 · Miller et al. · 2004 [cited by applicant]
US 6761703B2 · Miller et al. · 2004 [cited by applicant]
US 7070606B2 · Seward · 2006 [cited by applicant]
US 7115134B2 · Chambers · 2006 [cited by applicant]
US 7115183B2 · Larson et al. · 2006 [cited by applicant]
US 7166100B2 · Jordan et al. · 2007 [cited by applicant]
US 7247147B2 · Nishide · 2007 [cited by examiner]
US 7309334B2 · von Hoffmann · 2007 [cited by applicant]
US 7632242B2 · Griffin · 2009 [cited by examiner]
US 7708704B2 · Mitelberg et al. · 2010 [cited by applicant]
US 7708755B2 · Davis, III et al. · 2010 [cited by applicant]
US 7785317B2 · Mitelberg · 2010 [cited by applicant]
US 7815600B2 · Al-Marashi et al. · 2010 [cited by applicant]
US 8012117B2 · Bonnette et al. · 2011 [cited by applicant]
US 8021351B2 · Boldenow et al. · 2011 [cited by applicant]
US 8088121B2 · Nishide · 2012 [cited by examiner]
US 8317715B2 · Belleville et al. · 2012 [cited by applicant]
US 8323203B2 · Thornton · 2012 [cited by applicant]
US 8337518B2 · Nance et al. · 2012 [cited by applicant]
US 8454673B2 · Al-Marashi et al. · 2013 [cited by applicant]
US 8523841B2 · Itou et al. · 2013 [cited by applicant]
US 8585713B2 · Ferrera et al. · 2013 [cited by applicant]
US 8728116B1 · Janardhan et al. · 2014 [cited by applicant]
US 8758334B2 · Coe et al. · 2014 [cited by applicant]
US 8771329B2 · Christensen et al. · 2014 [cited by applicant]
US 8939931B2 · Von Hoffmann · 2015 [cited by applicant]
US 9005165B2 · Kalser et al. · 2015 [cited by applicant]
US 9060784B2 · Coe et al. · 2015 [cited by applicant]
US 9179995B2 · Janardhan et al. · 2015 [cited by applicant]
US 9289576B2 · Mann · 2016 [cited by examiner]
US 9301777B2 · Silvestro · 2016 [cited by applicant]
US 9339632B2 · Eidenschink · 2016 [cited by examiner]
US 9372217B2 · Hahl et al. · 2016 [cited by applicant]
US 9445784B2 · O'Keeffe · 2016 [cited by applicant]
US 9616195B2 · Lippert et al. · 2017 [cited by applicant]
US 9636173B2 · Goshgarian et al. · 2017 [cited by applicant]
US 9692557B2 · Murphy · 2017 [cited by applicant]
US 9833125B2 · Stigall et al. · 2017 [cited by applicant]
US 9861727B2 · Slager et al. · 2018 [cited by applicant]
US 9955852B2 · Kesten et al. · 2018 [cited by applicant]
US 10292573B2 · Stigall et al. · 2019 [cited by applicant]
US 10315018B2 · Eidenschink et al. · 2019 [cited by applicant]
US 10363389B2 · Lippert et al. · 2019 [cited by applicant]
US 10434292B2 · Joe et al. · 2019 [cited by applicant]
US 10449334B2 · Pillai · 2019 [cited by applicant]
US 10561820B2 · Sullivan et al. · 2020 [cited by applicant]
US 10568991B2 · Wang et al. · 2020 [cited by applicant]
US 10617847B2 · Cottone et al. · 2020 [cited by applicant]
US 10687690B2 · Kesten et al. · 2020 [cited by applicant]
US 10688277B2 · O'Connell et al. · 2020 [cited by applicant]
US 10709312B2 · Stigall et al. · 2020 [cited by applicant]
US 10980918B2 · Babcock et al. · 2021 [cited by applicant]
US 11000632B2 · Babcock et al. · 2021 [cited by applicant]
US 11865237B2 · Davis et al. · 2024 [cited by applicant]
US 20010049519A1 · Holman et al. · 2001 [cited by applicant]
US 20020007146A1 · Omaleki · 2002 [cited by examiner]
US 20030083691A1 · Wantink · 2003 [cited by examiner]
US 20050075661A1 · Levine et al. · 2005 [cited by applicant]
US 20050267408A1 · Grandt · 2005 [cited by examiner]
US 20060264904A1 · Kerby et al. · 2006 [cited by applicant]
US 20070016133A1 · Pepper · 2007 [cited by examiner]
US 20070060880A1 · Gregorich et al. · 2007 [cited by applicant]
US 20070073331A1 · Brown et al. · 2007 [cited by applicant]
US 20080077085A1 · Eidenschink et al. · 2008 [cited by applicant]
US 20080306441A1 · Brown et al. · 2008 [cited by applicant]
US 20110319905A1 · Palme et al. · 2011 [cited by applicant]
US 20120303054A1 · Wilson et al. · 2012 [cited by applicant]
US 20140193474A1 · Babcock et al. · 2014 [cited by applicant]
US 20140358074A1 · Wilson · 2014 [cited by examiner]
US 20150258307A1 · Osypka et al. · 2015 [cited by applicant]
US 20150305867A1 · Liu et al. · 2015 [cited by applicant]
US 20150374483A1 · Janardhan et al. · 2015 [cited by applicant]
US 20160339207A1 · Beeckler et al. · 2016 [cited by applicant]
US 20170165001A1 · Lyttle · 2017 [cited by applicant]
US 20170296221A1 · Di Caprio et al. · 2017 [cited by applicant]
US 20180042743A1 · Syed · 2018 [cited by applicant]
US 20180153669A1 · Herrera et al. · 2018 [cited by applicant]
US 20180250147A1 · Syed · 2018 [cited by applicant]
US 20190083757A1 · Torres et al. · 2019 [cited by applicant]
US 20190275260A1 · Ralph et al. · 2019 [cited by applicant]
US 20190298520A1 · Cooper et al. · 2019 [cited by applicant]
US 20200016378A1 · Williams et al. · 2020 [cited by applicant]
US 20200023164A1 · Tran et al. · 2020 [cited by applicant]
US 20200060723A1 · Walzman · 2020 [cited by applicant]
US 20200078551A1 · Moquin et al. · 2020 [cited by applicant]
US 20200078554A1 · Walzman · 2020 [cited by applicant]
US 20200222664A1 · Cottone et al. · 2020 [cited by applicant]
US 20200230359A1 · Fojtik et al. · 2020 [cited by applicant]
US 20210322732A1 · Davis · 2021 [cited by applicant]
US 20240157097A1 · Davis et al. · 2024 [cited by applicant]
CN 101479006 · 2009 [cited by applicant]
CN 101588835 · 2009 [cited by applicant]
CN 106166067 · 2016 [cited by applicant]
CN 108211084 · 2018 [cited by applicant]
CN 110236600 · 2019 [cited by applicant]
CN 115666699 · 2023 [cited by applicant]
JP 2018099521 · 2018 [cited by applicant]
JP 2019071914 · 2019 [cited by applicant]
JP 2023522978 · 2023 [cited by applicant]
WO WO2021216442A1 · 2021 [cited by applicant]
WO 2023034492 · 2023 [cited by applicant]
“U.S. Appl. No. 17/234,206, Corrected Notice of Allowability mailed Sep. 7, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/234,206, Corrected Notice of Allowability mailed Dec. 6, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/234,206, Notice of Allowance mailed Aug. 23, 2023”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 18/516,464, Preliminary Amendment filed Feb. 6, 2024”, 7 pgs. [cited by applicant]
“European Application Serial No. 21793660.8, Extended European Search Report mailed Jan. 23, 2024”, 13 pgs. [cited by applicant]
“European Application Serial No. 21793660.8, Partial Supplementary European Search Report mailed Oct. 19, 2023”, 13 pgs. [cited by applicant]
“International Application Serial No. PCT/US2021/027947, International Search Report mailed Aug. 3, 2021”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2021/027947, Written Opinion mailed Aug. 3, 2021”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT US2022 042326, International Preliminary Report on Patentability mailed Mar. 14, 2024”, 7 pgs. [cited by applicant]
“European Application Serial No. 21793660.8, Response filed Jul. 31, 2024 to Extended European Search Report mailed Jan. 23, 2024”, 14 pgs. [cited by applicant]
“U.S. Appl. No. 18/516,464, Non Final Office Action mailed Oct. 1, 2024”, 13 pgs. [cited by applicant]
“European Application Serial No. 22865553.6, Extended European Search Report mailed Dec. 2, 2024”, 10 pgs. [cited by applicant]
“International Application Serial No. PCT US2021 027947, International Preliminary Report on Patentability mailed Nov. 3, 2022”, 9 pgs. [cited by applicant]
“International Application Serial No. PCT US2022 042326, International Search Report mailed Dec. 22, 2022”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT US2022 042326, Written Opinion mailed Dec. 22, 2022”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 17/234,206, Non Final Office Action mailed Jan. 31, 2023”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/234,206, Response filed May 1, 2023 to Non Final Office Action mailed Jan. 31, 2023”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 17/234,206, Examiner Interview Summary mailed May 3, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 18/516,464, Response filed Jan. 2, 2025 to Non Final Office Action mailed Oct. 1, 2024”, 13 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-564224, Notification of Reasons for Rejection mailed Feb. 12, 2025”, W English Translation, 13 pgs. [cited by applicant]
“U.S. Appl. No. 18/516,464, Final Office Action mailed Mar. 31, 2025”, 12 pgs. [cited by applicant]
“Chinese Application Serial No. 202180036481.X, Office Action mailed Mar. 26, 2025”, W English Translation, 17 pgs. [cited by applicant]
“European Application Serial No. 22865553.6, Response filed Jun. 19, 2025 to Extended European Search Report mailed Dec. 2, 2024”, w English Claims, 25 pgs. [cited by applicant]
“U.S. Appl. No. 18/516,464, Response filed Jun. 30, 2025 to Final Office Action mailed Mar. 31, 2025”, 11 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-564224, Response filed Jul. 2, 2025 to Notification of Reasons for Rejection mailed Feb. 12, 2025”, w English Claims, 12 pgs. [cited by applicant]
“U.S. Appl. No. 18/516,464, Advisory Action mailed Jul. 22, 2025”, 3 pgs. [cited by applicant]
“Chinese Application Serial No. 202180036481.X, Response filed Jul. 28, 2025 to Office Action mailed Mar. 26, 2025”, W English Claims, 35 pgs. [cited by applicant]
“U.S. Appl. No. 18/516,464, Response filed Sep. 30, 2025 to Advisory Action mailed Jul. 22, 2025”, 11 pgs. [cited by applicant]
“Chinese Application Serial No. 202180036481.X, Office Action mailed Oct. 14, 2025”, W English Translation, 11 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-564224, Examiners Decision of Final Refusal mailed Oct. 28, 2025”, W English Translation, 9 pgs. [cited by applicant]
“U.S. Appl. No. 18/516,464, Advisory Action mailed Nov. 6, 2025”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 18/516,464, Non Final Office Action mailed Dec. 5, 2025”, 15 pgs. [cited by applicant]
“Chinese Application Serial No. 202180036481.X, Response filed Dec. 15, 2025 to Office Action mailed Oct. 14, 2025”, w/English Claims, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-564224, Response filed Feb. 27, 2026 to Examiners Decision of Final Refusal mailed Oct. 28, 2025”, w/ English claims, 16 pgs. [cited by applicant]